Literature DB >> 19325900

Infection after ICD implantation: operating room versus cardiac catheterisation laboratory.

H H F Remmelts1, M Meine, P Loh, R Hauer, P A Doevendans, L A van Herwerden, T E M Hopmans, P M Ellerbroek.   

Abstract

BACKGROUND/
OBJECTIVES: Since the insertion of an implantable cardioverter-defibrillator (ICD) has become technically comparable to pacemaker implantation, these procedures are increasingly being performed in a cardiac catheterisation laboratory (CCL) instead of the operating room (OR). This study aims to describe the relationship between incidence of ICD infection and procedure setting and to describe the characteristics of ICD infection.
METHODS: A retrospective study was performed of first ICD implantation in 677 patients admitted to our hospital between 1996 and 2006. Implantations were performed in the OR until 2003, after 2003 they were carried out in the CCL. The follow-up was censored at one year after implantation. ICD infections were defined as pocket infection or ICD-related endocarditis and a descriptive analysis was performed.
RESULTS: Cardiothoracic surgeons implanted 366 ICDs in the OR Electrophysiologists performed 301 implantations in the CCL. Pulse generators were inserted using a pectoral approach with transvenous lead systems. We identified seven ICD infections (incidence rate 1.2/100 person-years), three of which had been implanted in the OR and four in the CCL.
CONCLUSION: In this single-centre study no difference in the incidence of ICD infection was observed between implantation in OR and CCL. However, a larger study will be necessary to rule out a relationship with certainty. (Neth Heart J 2009;17:95-100.).

Entities:  

Keywords:  cardiac catheterisation laboratory; complications; implantable cardioverter-defibrillator; infection; operating room

Year:  2009        PMID: 19325900      PMCID: PMC2659861          DOI: 10.1007/BF03086226

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  14 in total

Review 1.  Intravascular device infections: epidemiology, diagnosis, and management.

Authors:  Glenn Gandelman; William H Frishman; Cristina Wiese; Vanessa Green-Gastwirth; Steven Hong; Wilbert S Aronow; Harold W Horowitz
Journal:  Cardiol Rev       Date:  2007 Jan-Feb       Impact factor: 2.644

2.  Infections of implantable cardioverter-defibrillators: frequency, predisposing factors and clinical significance.

Authors:  P Gil; M L Fernández Guerrero; J F Bayona; J M Rubio; M de Górgolas; J J Granizo; J Farré
Journal:  Clin Microbiol Infect       Date:  2006-06       Impact factor: 8.067

3.  ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Jean-Jacques Blanc; Andrzej Budaj; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-25       Impact factor: 29.690

4.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

5.  Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants.

Authors:  T Mela; B A McGovern; H Garan; G J Vlahakes; D F Torchiana; J Ruskin; J M Galvin
Journal:  Am J Cardiol       Date:  2001-10-01       Impact factor: 2.778

6.  Diagnosis and management of infections involving implantable electrophysiologic cardiac devices.

Authors:  J D Chua; B L Wilkoff; I Lee; N Juratli; D L Longworth; S M Gordon
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

7.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.

Authors:  Muhammad R Sohail; Daniel Z Uslan; Akbar H Khan; Paul A Friedman; David L Hayes; Walter R Wilson; James M Steckelberg; Sarah Stoner; Larry M Baddour
Journal:  J Am Coll Cardiol       Date:  2007-04-23       Impact factor: 24.094

8.  Infection after ICD implantation: operating room versus cardiac catheterisation laboratory.

Authors:  H H F Remmelts; M Meine; P Loh; R Hauer; P A Doevendans; L A van Herwerden; T E M Hopmans; P M Ellerbroek
Journal:  Neth Heart J       Date:  2009-03       Impact factor: 2.380

9.  Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study.

Authors:  Daniel Z Uslan; Muhammad R Sohail; Jennifer L St Sauver; Paul A Friedman; David L Hayes; Sarah M Stoner; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  Arch Intern Med       Date:  2007-04-09

10.  Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years.

Authors:  H J Trappe; P Pfitzner; H Klein; P Wenzlaff
Journal:  Br Heart J       Date:  1995-01
View more
  8 in total

1.  Primary prevention with ICDs, are we on the right track?

Authors:  A A M Wilde; T A Simmers
Journal:  Neth Heart J       Date:  2009-03       Impact factor: 2.380

2.  Implantable electrophysiologic cardiac device infections: a risk factor analysis.

Authors:  D Raad; J Irani; E G Akl; S Choueiri; E Azar; J Abboud; C Afif
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-25       Impact factor: 3.267

3.  Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.

Authors:  Archana Asundi; Maggie Stanislawski; Payal Mehta; Anna E Baron; Hillary J Mull; P Michael Ho; Peter J Zimetbaum; Kalpana Gupta; Westyn Branch-Elliman
Journal:  Infect Control Hosp Epidemiol       Date:  2019-06-04       Impact factor: 3.254

4.  Infection after ICD implantation: operating room versus cardiac catheterisation laboratory.

Authors:  H H F Remmelts; M Meine; P Loh; R Hauer; P A Doevendans; L A van Herwerden; T E M Hopmans; P M Ellerbroek
Journal:  Neth Heart J       Date:  2009-03       Impact factor: 2.380

Review 5.  Adverse events following implantable cardioverter defibrillator implantation: a systematic review.

Authors:  Rebecca Persson; Amy Earley; Ann C Garlitski; Ethan M Balk; Katrin Uhlig
Journal:  J Interv Card Electrophysiol       Date:  2014-06-20       Impact factor: 1.900

6.  Infective complications after transcatheter aortic valve implantation: results from a single centre.

Authors:  K Onsea; P Agostoni; M Voskuil; M Samim; P R Stella
Journal:  Neth Heart J       Date:  2012-09       Impact factor: 2.380

7.  Clinical experience with a novel subcutaneous implantable defibrillator system in a single center.

Authors:  Lara Dabiri Abkenari; Dominic A M J Theuns; Suzanne D A Valk; Yves Van Belle; Natasja M de Groot; David Haitsma; Agnes Muskens-Heemskerk; Tamas Szili-Torok; Luc Jordaens
Journal:  Clin Res Cardiol       Date:  2011-03-17       Impact factor: 5.460

8.  Pseudomonas aeruginosa Infective Endocarditis Following Aortic Valve Implantation: A Note of Caution.

Authors:  Juan Ignacio Dapás; Cynthia Rivero; Pablo Burgos; Andrea Vila
Journal:  Open Cardiovasc Med J       Date:  2016-02-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.